v3.26.3
Business Combinations (Tables)
 12 Months Ended
Apr. 30, 2026
Business Combinations [Abstract]  
Schedule of Cash Consideration

The fair value of the consideration transferred is as follows:

 

    JPY  
Cash consideration     547,120,001  
Ordinary shares issued (American Depositary Shares)     539,322,124  
Series P preference shares issued (American Depositary Shares)     6,165,219,979  
Deferred cash consideration     1,743,333,735  
Total fair value of consideration transferred     8,994,995,839  
Schedule of Results Included Since the Acquisition Date

The following amounts represent the acquired PML subgroup’s results included in the consolidated statement of operations from the Acquisition Date through April 30, 2026:

 

    January 20,
2026
through
April 30,
2026		  
    JPY  
Revenue, net     13,200,204  
Net loss     (319,862,071 )
Schedule of Pro Forma Information
    As of
April 30,
2024		     As of
April 30,
2025		  
    Euro     Euro  
Cash     204,682-       588,182  
Trade accounts receivable, net     -       130,446  
Receivables from related parties     1,100-       17,065  
Value added tax receivable     13,163       97,265  
Other receivables – Sale of Investment     -       17,939  
Other receivables     1,133       6,965  
Prepayments and other current assets     3,094       11,190  
                 
Total current assets     223,172       869,052  
                 
Property and equipment, net     -       210,190  
Equity method investments     -       64,162  
Operating right-of-use assets     -       302,601  
                 
Total Non-current assets     -       576,953  
                 
Total assets     223,172       1,446,005  
                 
Trade accounts payable     (6,627 )     (51,261 )
Accrued expenses     (9,584 )     (62,395 )
Value added tax payable     -       (62,769 )
Other payables     -       (5,033 )
Payables to related parties     (2,037 )     (206,382 )
Loans to related parties, current     -       (40,250 )
Operating lease liabilities, current     -       (106,081 )
                 
Total current liabilities     (18,248 )     (534,171 )
                 
Long-term liabilities:                
Loans to related parties, noncurrent     (406,932 )     (1,096,679 )
Operating lease liabilities, noncurrent     -       (188,350 )
Post-employment retirement benefits liability     -       (34,127 )
                 
Total non-current liabilities     (406,932 )     (1,319,156 )
                 
Total liabilities     (425,180 )     (1,853,327 )
                 
Commitments and contingencies                
Mezzanine equity:Participating Convertible Preference Virtual Shares: nil and 470 shares as of April 30, 2024, and 2025, respectively     -       (1,762,357 )
Shareholders’ deficit:                
Class A Ordinary Voting Shares, par value €1 per share: 2,000 shares authorized, issued, and outstanding as of April 30, 2024 and 2025, respectively     (2,000 )     (2,000 )
Class B Ordinary Non-Voting Shares, par value €1 per share: nil and 100,000 shares authorized as of April 30, 2024 and 2025, respectively; nil and 18,000 shares issued and outstanding as of April 30, 2024 and 2025, respectively     -       (18,000 )
Class C Redeemable Preference Shares, par value €1 per share: nil and 10,000 shares authorized as of April 30, 2024 and 2025, respectively; nil shares issued and outstanding as of April 30, 2024 and 2025     -       -  
Additional paid-in capital     -       -  
Accumulated deficit     203,818       2,193,439  
Accumulated other comprehensive income     190       (3,760 )
                 
Total shareholders’ deficit     202,008       2,169,679  
                 
Total liabilities, mezzanine equity and shareholders’ deficit     (223,172 )     (1,446,005 )
Schedule of Pro Forma Information Income Statement

 

    For the year ended
April 30,
2024		     For the year ended
April 30,
2025		  
    Euro     Euro  
Revenue, net     -       (340,581 )
                 
Cost of revenue     -       199,440  
                 
Gross income     -       (141,141 )
                 
General and administrative expenses     193,949       1,388,257  
Research and development expenses     -       785,426  
Operating Loss     193,949       2,173,683  
                 
Interest expenses, net     6,933       127,206  
Gain from the sale of controlling interests in ESGCX     -       (179,174 )
Impairment of goodwill     -       82,379  
Foreign currency remeasurement gain     -       (77,203 )
Other (expense) income, net     2,936       1,322  
                 
Total other income (expense), net     9,869       (45,470 )
                 
LOSS BEFORE INCOME TAXES     203,818       1,987,072  
                 
Provision for income tax     -       -  
                 
Loss before equity in net loss of equity method investment     203,818       1,987,072  
                 
Equity in losses of equity method investee     -       2,549  
                 
Net Loss     203,818       1,989,621  
                 
Weighted average shares                
Basic     2,000       11,541  
Diluted     2,000       11,541  
Loss per share (basic)     101.91       172.40  
Loss per share (diluted)     101.91       172.40  
                 
Other comprehensive loss:                
Foreign currency translation adjustments     190       (3,950 )
Release of cumulative translation adjustment upon disposal of a foreign subsidiary                
                 
Total comprehensive loss     204,008       1,985,671